Our results on two different ovarian cancer cell lines show that MMP2 is expressed nearly 5–6 folds higher in cells isolated from malignant ascites (in vitro cell culture and ex vivo tumor xenograft) obtained from patients with advanced ovarian carcinoma when compared with A2780 ovarian cancer cells (Fig. 2a). This evidence concerns the gene MMP2 and ovarian carcinoma.